4th Annual Protein Folding Diseases Initiative Symposium

The University of Michigan’s Protein Folding Diseases Initiative will be holding its 4^th Annual Symposium on Thursday, October 12, from 9:00 am until 4:30 pm, at the A. Alfred Taubman Biomedical Science Research Building (BSRB), Kahn Auditorium, on the University’s Medical Campus.

 

REGISTER HERE

Facebook Live Video Highlights New Frontiers in Pathology Conference

Histopathologic Comparison of Epidermotropic Melanoma Metastases and Primary Nodular Melanoma

New FISH Assays to Aid Renal Cancer Diagnosis

Life as a Pediatric Pathology Fellow

Interview of Pediatric Fellow Nathan Shaller, MD

The Smallest Among Us

Rajah Rabah, MD works to make autopsy reports more accessible to families and change the perceptions of pediatric pathology.

New Frontiers in Pathology Conference

This symposium is intended to address the educational requirements for practicing pathologists, residents and fellows. Diagnostic problems in Anatomic Pathology will be identified and evaluated using current tools.

View Site  Register Now

Sriram Venneti receives ASCI young Physician-Scientist Award

Sriram Venneti, MD, PhD, was awarded the American Society for Clinical Investigation Council Young Physician-Scientist Award. This award was initiated in 2013 and recognizes young physician-scientists who are supported by NIH K or similar significant career-development awards, are early in their first faculty appointment, and have made notable achievements in their research.

Senior resident publishes Breast Pathology consultation practice at Michigan Medicine

Fourth year resident, Ellen East, MD, was recently published in Archives of Pathology & Laboratory Medicine. Under the guidance of Julie Jorns, MD, East investigated the practice of breast pathology consultation at a large tertiary care center. Learn more in Characteristics of a Breast Pathology Consultation Practice.

Recent Faculty Directorships

Congratulations to the recently appointed Laboratory Directors within the Anatomic Pathology Division!

Dr. Judy Pang has done an amazing job as the interim Cytopathology Director; so amazing, in fact, that she was unanimously chosen to stay at the helm as the Cytopathology Director! Congrats to Dr. Pang!  Stepping into Dr. Pang's shoes is Dr. Andrew Sciallis, who will be taking over as the Immunohistochemistry Lab Director.

[ ... ]

Disruptive Innovations Lead to New Global Impact Opportunities in Pathology

Chief Resident, Cody Carter, MD, writes about the disruptive technological innovations in histology and digital pathology that are shaking up Global Outreach possibilities in the field. He discusses the new opportunities to make a diagnostic impact for patients in Sub-Saharan Africa from the comfort of your office in No Longer an Excuse. Read it in the American Society for Clinical Pathology's quarterly publication, Critical Values.

Laura W. Lamps, MD wins the President’s Award at USCAP, 2017

Each year, the President and Executive Committee of the United States and Canadian Academy of Pathology have the opportunity to recognize an individual for outstanding service to the field and to the Academy. This year, Laura W. Lamps, MD received the honor. Dr. Lamps is the Godfrey D. Stobbe Professor of Gastrointestinal Pathology and also serves as Michigan Medicine’s Patient Safety Officer. [ ... ]

Collaboration Leads to Time-Saving Microscopic Imaging Technique

Anatomic Pathology—Sandra Camelo-Piragua, MD

New Director of Gastrointestinal Pathology, Laura Lamps, MD

Long-time friend joins the Michigan Medicine family

Allecia Wilson, MD Named President of the Michigan Association of Medical Examiners

Assistant Professor of Forensic Pathology and Director of the Residency Training Program, Allecia Wilson, MD has been named President of the Michigan Association of Medical Examiners (MAME). MAME's mission is to foster the highest professional standards in the performance of the duties of the county medical examiners of Michigan. [ ... ]

New Breast Cancer Metastasis Mechanism Uncovered

The laboratory of Dr. Celina Kleer, Harold A. Oberman Collegiate Professor, isolated human mesenchymal stem cells from breast cancer metastasis. The lab discovered that a collagen receptor tyrosine kinase, DDR2, mediates stromal-cancer communication and induces breast cancer metastasis. The study provides the basis for the development of DDR2 inhibitors. The article appeared in Cell Reports and can be found at www.cell.com.

What Cancer Patients Should Know About Their Pathology Reports

If you have cancer, the treatment plan probably started with a pathologist’s review of your biopsy